- Report
- January 2025
- 170 Pages
Global
From €5261EUR$5,950USD£4,489GBP
- Report
- June 2025
- 93 Pages
Global
From €5172EUR$5,850USD£4,413GBP
- Report
- February 2024
- 182 Pages
Global
From €3382EUR$3,825USD£2,885GBP
€3979EUR$4,500USD£3,395GBP
- Report
- October 2023
- 71 Pages
Global
From €3500EUR$4,240USD£3,091GBP
- Report
- October 2023
- 146 Pages
Global
From €3669EUR$4,150USD£3,131GBP
The Implantable Miniature Telescope (IMT) is an innovative medical device used to treat age-related macular degeneration (AMD). It is a tiny telescope that is surgically implanted in the eye, allowing patients to see better and more clearly. The IMT works by magnifying images and projecting them onto the healthy part of the retina, allowing the patient to see more clearly. The device is designed to be minimally invasive and can be implanted in a single outpatient procedure.
The IMT market is growing rapidly as more people are being diagnosed with AMD and the device is becoming more widely available. The device is also becoming more affordable, making it accessible to a wider range of patients. The IMT is a promising technology that has the potential to improve the quality of life for those suffering from AMD.
Some companies in the IMT market include VisionCare Ophthalmic Technologies, Inc., OptoVue, Inc., and CentraSight. Show Less Read more